Covid-19 project attracts US$2.8m funding
Royal Philips and continuous health monitoring company BioIntelliSense will receive almost US$2.8m from the US Department of Defense (DoD) to validate the BioIntelliSense Food and Drug Administration-cleared BioSticker for the early detection of Covid-19 symptoms.
The goal is to accelerate the use of wearable diagnostics for the benefit of military and public health through the early identification and containment of pre-symptomatic Covid-19 cases.
For the full story, see the February 2021 edition of Smart Textiles & Wearables.